Concepedia
Statistics
Publications
32
Citations
2.8K
H-Index
24
Active since
1981
Affiliations
National Cancer Institute(Current)
National Institutes of Health
Center for Biologics Evaluation and Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
M Stetler-Stevenson is an author at National Cancer Institute specializing in medicine, oncology, and lymphoid neoplasms.
Publications per year
1981–2013
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
Liliana Guédez, William G. Stetler‐Stevenson, Linda Wolff et al. · Journal of Clinical Investigation · 1998 · 399 citations · Full text
Medicine, Cancer Biology, Oncology +13
Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275
Gurmeet Kaur, M Stetler-Stevenson, S Sebers et al. · JNCI Journal of the National Cancer Institute · 1992 · 351 citations
Medicine, Oncology, Pharmacology +13
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin
CB Cooke, László Krenács, M Stetler-Stevenson et al. · Blood · 1996 · 286 citations · Full text
Veterinary Medicine, Oncology, Pathology +8
CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation
Judy Gray, Makoto Haino, Monica J. Roth et al. · The Journal of Immunology · 1996 · 199 citations
Life Sciences, Cell Biology, Molecular Biology +14
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study
EA Sausville, Donna Headlee, M Stetler-Stevenson et al. · Blood · 1995 · 166 citations · Full text
Medicine, Hematology, Oncology +8
1–5 of 32